Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Edan Instruments Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Hao Zhang

İcra Kurulu Başkanı

CN¥2.0m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	14.6yrs
CEO sahipliği	21.1%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	13.1yrs

Son yönetim güncellemeleri

Recent updates

There's Reason For Concern Over Edan Instruments, Inc.'s (SZSE:300206) Massive 28% Price Jump

Oct 01

Edan Instruments (SZSE:300206) Has Affirmed Its Dividend Of CN¥0.207

Apr 29

Why Investors Shouldn't Be Surprised By Edan Instruments, Inc.'s (SZSE:300206) 25% Share Price Plunge

Apr 18

Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 04

Edan Instruments, Inc.'s (SZSE:300206) Shares Bounce 28% But Its Business Still Trails The Market

Mar 04

CEO

Hao Zhang (60 yo)

14.6yrs

Görev süresi

CN¥2,016,900

Tazminat

Mr. Hao Zhang serves as the Chairman and President at Edan Instruments, Inc. Mr. Zhang has a Master’s Degree.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Hao Zhang	Chairman & President	14.6yrs	CN¥2.02m	21.05% CN¥ 1.4b
Youdong Zu	CFO, VP	14.6yrs	CN¥1.62m	17.27% CN¥ 1.1b
Xicheng Xie	VP & Non-Independent Director	14.6yrs	CN¥1.62m	17.18% CN¥ 1.1b
Yang Su	Independent Director	14.6yrs	CN¥150.00k	Veri yok
Chun Zhou	Chairman of Supervisory Board	11.7yrs	CN¥98.80k	Veri yok
Chun Li	Independent Director	14.6yrs	CN¥150.00k	Veri yok
Hongchao Wang	Non-Employee Supervisor	5.9yrs	Veri yok	Veri yok
Quanlu Zheng	Independent Director	2.5yrs	CN¥150.00k	Veri yok
Yirong Zhou	Non-Employee Supervisor	4.4yrs	Veri yok	Veri yok
Shixin Yuan	Independent Outside Director	1.6yrs	CN¥104.20k	Veri yok

13.1yrs

Ortalama Görev Süresi

59.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300206's board of directors are seasoned and experienced ( 13.1 years average tenure).

Edan Instruments Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

High number of new directors

High number of new directors

Recent updates

There's Reason For Concern Over Edan Instruments, Inc.'s (SZSE:300206) Massive 28% Price Jump

Edan Instruments, Inc. to Report Q3, 2024 Results on Oct 25, 2024

Investor sentiment improves as stock rises 27%

Now 21% overvalued after recent price rise

Edan Instruments, Inc. to Report First Half, 2024 Results on Aug 30, 2024

Edan Instruments (SZSE:300206) Has Affirmed Its Dividend Of CN¥0.207

Dividend of CN¥0.21 announced

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: CN¥0.066 (vs CN¥0.24 in 1Q 2023)

Why Investors Shouldn't Be Surprised By Edan Instruments, Inc.'s (SZSE:300206) 25% Share Price Plunge

Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Edan Instruments, Inc. to Report Q1, 2024 Results on Apr 26, 2024

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.40 in FY 2022)

Investor sentiment improves as stock rises 33%

Edan Instruments, Inc.'s (SZSE:300206) Shares Bounce 28% But Its Business Still Trails The Market

Investor sentiment deteriorates as stock falls 16%

Edan Instruments, Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023

Third quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.068 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.17 in 2Q 2022)

Edan Instruments, Inc. to Report First Half, 2023 Results on Aug 23, 2023

First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.085 in 1Q 2022)

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.11 in 3Q 2021)

Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.10 in 2Q 2021)

Edan Instruments, Inc. Launches i20

High number of new directors

High number of new directors

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022

Edan Instruments, Inc. Approves Distribution for 2021

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.67 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.14 in 1Q 2020)

Edan Instruments, Inc. Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥1.12 (vs CN¥0.23 in FY 2019)

New 90-day high: CN¥19.94

Investor sentiment improved over the past week

New 90-day low: CN¥16.31

Edan Instruments, Inc. to Report Fiscal Year 2020 Results on Mar 15, 2021

New 90-day low: CN¥16.65

New 90-day low: CN¥16.72

New 90-day low: CN¥19.12

Third quarter earnings released

Edan Instruments, Inc. to Report Q3, 2020 Results on Oct 27, 2020

First half earnings released

Edan Instruments, Inc. to Report First Half, 2020 Results on Aug 21, 2020

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş